Technology-driven strategy, globally scaled delivery, patient access partnerships, and top pharma focus have made Trialbee the fastest growing platform in recruitment
MAMO, Sweden and WILMINGTON, Del., Jan. 30, 2025 /PRNewswire-PRWeb/ -- Trialbee, the global leader in technology-driven patient recruitment for clinical trials, looks back on an impactful 2024 defined by strong partnerships, innovative advancements, and significant growth. Among other accomplishments, the company doubled revenue, added two additional Top 20 pharmaceutical companies and two Top 10 CRO companies as new customers, supported studies across 49 countries in 66 languages, and surpassed 2,500 research sites connected with its Trialbee Honey™ Patient Recruitment Platform (PRP).
Trialbee's achievements in 2024 include…
- Financial Performance: Increased revenue by 115% and new sales bookings by 135%
- Quality Referrals: Achieved a 30% referral-to-consent ratio (more than double the industry average) while reducing the volume sent to sites by 78% due to medical secondary screening
- Customer Value: Added three new Top 20 pharmaceutical companies, two new Top 10 CRO companies while announcing new Omnichannel Network partnerships with Inspire, Evidation, Belong,Life, and Massive Bio
- Global Reach: Expanded its international team by nearly 20%, broadened its services to 49 countries and 66 languages, and 30% of the trials it supported were part of global multi-study programs
- Technology Leadership: Launched new capabilities in the Honey Platform including site workflows, program-level re-matching, and enhanced Insights and ROI reporting. Weekly user adoption of Trialbee Honey grew to 80% for sites (vs. 60% industry average) and 95% for study teams
CEO Matt Walz expressed gratitude to customers, research sites and partners, whose trust and collaboration have been central to the company's success.
"2024 was a redefining year for Trialbee, and for global patient recruitment in general," said Walz. "As more and more study teams experience the value of PRPs, they are increasingly being creative about new ways to leverage cloud technology to support large global programs more efficiently and effectively to reduce costs while keeping patients at the center of focus and minimizing the burden at research sites. We are proud of the trust that leading pharmaceutical companies have placed in us to support their pivotal studies and deliver for them at global scale."
As Trialbee prepares for 2025, it is focused on deepening customer relationships and continuing to advance the expectations and quality of what is possible with technology-driven patient recruitment for global clinical trials.
Walz added, "This is the most rewarding job I've ever had, and we have much more planned for the year ahead. The best part is, we have great relationships with our customers, and we get to do it all with a truly global team and culture that is humble, kind, curious, and fun. Personally, I can't wait to see what this team accomplishes together this year."
To take control of your global patient recruitment, visit www.trialbee.com.
About Trialbee
Trialbee is revolutionizing the patient recruitment ecosystem with technology, people, and passion. The company's vendor-agnostic Honey Platform™ is a SaaS Patient Recruitment Platform that centralizes and standardizes all recruitment activities from every source, channel, and partner from interest through enrollment — providing unprecedented transparency and actionable insights for real-time patient tracking, higher-quality referrals that reduce site burden, and robust ROI reporting. Honey is surrounded by a team of Precision Recruitment experts who meet patients where they are in their journey with data-driven modeling based on consumer behavior and other real-world data, hyper-targeted digital outreach, two-step pre-qualification, and meaningful Omnichannel partners focused on meeting patients where they are in the treatment journey. To take control of patient recruitment for your next study, visit trialbee.com and follow us on LinkedIn.
Media Contact
Kristopher Sarajian, Trialbee, 46 101 963 260, [email protected], www.trialbee.com
SOURCE Trialbee
Share this article